← Back to Clinical Trials
Recruiting NCT06375551

NCT06375551 K-ORCA: Testing a Decision Support Tool and Group Process for Selecting Interventions

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06375551
Status Recruiting
Phase
Sponsor Chestnut Health Systems
Condition Child Abuse
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2026-05-31
Primary Completion 2027-07-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Optimizing Responses with Collaborative Assessments-Automated (ORCA-A)Optimizing Responses with Collaborative Assessments-Live (ORCA-L)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2026-05-31 with a primary completion date of 2027-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This proposal responds to NIMH Objective 4.2.c to develop "decision-support tools and technologies that increase the effectiveness and continuous improvement of mental health interventions" by leveraging the Family First Prevention Services Act (FFPSA) policy opportunity. First, a web-based platform to host (a) a decision-support tool and (b) automated facilitation for group decisions with the tool will be developed with state partners' feedback. Next, decision makers leading their states' FFPSA quality improvement efforts will be engaged to pilot a decision-support intervention comprised of the tool and live or automated facilitation, and to evaluate the implementation quality of evidence-based programs adopted with the decision-support intervention.

Eligibility Criteria

Inclusion Criteria: * Non-institutionalized * Adults (18 years or older). * English-Speaking Aim 1: * Involved in initial state decision-making related to Family First Prevention Services Act. * Willing to participate in two data collection occasions. Aim 2: * Non-institutionalized * Adults (18 years or older). English-Speaking. * Involved in ongoing state decision-making related to Family First Prevention Services Act. * Willing to participate in three measurement occasions. Aim 3: -Willing to participate in multiple (bi-weekly up to two years) measurement occasions. Exclusion Criteria: -Not involved in or potentially influencing child welfare intervention decisions

Contact & Investigator

Central Contact

Gracelyn Cruden, PhD

✉ gcruden@chestnut.org

📞 843-513-9928

Principal Investigator

Gracelyn Cruden, PhD

PRINCIPAL INVESTIGATOR

Chestnut Health Systems

Frequently Asked Questions

Who can join the NCT06375551 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Child Abuse. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06375551 currently recruiting?

Yes, NCT06375551 is actively recruiting participants. Contact the research team at gcruden@chestnut.org for enrollment information.

Where is the NCT06375551 trial being conducted?

This trial is being conducted at Eugene, United States.

Who is sponsoring the NCT06375551 clinical trial?

NCT06375551 is sponsored by Chestnut Health Systems. The principal investigator is Gracelyn Cruden, PhD at Chestnut Health Systems. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology